Cancer

Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update

  Revenue for the first three months of 2023 increased to $15.9 million, compared to $0.8 million for the same…

1 year ago

Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update

Revenue for the first three months of 2023 increased to $15.9 million, compared to $0.8 million for the same period…

1 year ago

BeyondSpring and Leading Cancer Center to Present Poster at 2023 ASCO Annual Meeting

NEW YORK, May 18, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical…

1 year ago

Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer

VANCOUVER, British Columbia, May 18, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional…

1 year ago

MiNK’s Novel FAP-CAR-iNKT Presented at ASGCT

FAP-CAR-IL-15 iNKT cell therapy (MiNK-215) promotes curative responses driving tumor elimination and immune infiltration in NSCLC modelsIND enabling studies underway;…

1 year ago

Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals

18 May 2023 Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals Biodexa Pharmaceuticals PLC…

1 year ago

Mustang Bio Announces Strategic Manufacturing Partnership and Portfolio Updates

uBriGene (Boston) Biosciences to acquire Mustang Bio’s Worcester manufacturing facility for total consideration of up to $11 million and enters…

1 year ago

PDS Biotech Completes Enrollment in Immune Checkpoint Inhibitor Naïve Arm of VERSATILE-002 Phase 2 Clinical Trial in Advanced HPV16 Positive Head and Neck Cancer

Company plans to initiate VERSATILE-003 Phase 3 clinical trial in late 2023FLORHAM PARK, N.J., May 18, 2023 (GLOBE NEWSWIRE) --…

1 year ago

Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference

TORONTO, May 18, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device…

1 year ago